You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-MET (MET) Antibodies

Full name:
anti-Met Proto-Oncogene Antibodies (MET)
On www.antibodies-online.com are 690 Met Proto-Oncogene (MET) Antibodies from 32 different suppliers available. Additionally we are shipping MET Kits (56) and MET Proteins (50) and many more products for this protein. A total of 822 MET products are currently listed.
Synonyms:
AI838057, AUTS9, c-met, HGF, Hgfr, Par4, RCCP2
list all antibodies Gene Name GeneID UniProt
MET 4233 P08581
MET 17295  
MET 24553 P97523

Show all species

Show all synonyms

All available anti-MET Antibodies

Go to our pre-filtered search.

Top referenced anti-MET Antibodies

  1. Human Monoclonal MET Primary Antibody for FACS, IHC (p) - ABIN1688523 : Zagouri, Bago-Horvath, Rössler, Brandstetter, Bartsch, Papadimitriou, Dimitrakakis, Tsigginou, Papaspyrou, Giannos, Dimopoulos, Filipits: High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer. in British journal of cancer 2013 (PubMed)
    Show all 36 references for ABIN1688523

  2. Human Polyclonal MET Primary Antibody for WB - ABIN197478 : Fan, Ma, Gao, Yuan, Meng, Goldberg, Rosen: The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. in Molecular and cellular biology 2001 (PubMed)
    Show all 5 references for ABIN197478

  3. Human Polyclonal MET Primary Antibody for EIA, IHC (p) - ABIN358164 : Wong, Roskelley, Pelech, Miller, Leung, Auersperg: Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation. in Experimental cell research 2004 (PubMed)
    Show all 5 references for ABIN358164

  4. Human Polyclonal MET Primary Antibody for EIA, WB - ABIN358165 : Higuchi, Orita, Katsuya, Yamasaki, Akiyama, Li, Yamamoto, Saito, Nakamura: MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met. in Molecular and cellular biology 2004 (PubMed)
    Show all 5 references for ABIN358165

  5. Human Polyclonal MET Primary Antibody for WB - ABIN197460 : Gherardi, Youles, Miguel, Blundell, Iamele, Gough, Bandyopadhyay, Hartmann, Butler: Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor. in Proceedings of the National Academy of Sciences of the United States of America 2003 (PubMed)
    Show all 4 references for ABIN197460

  6. Human Polyclonal MET Primary Antibody for EIA, WB - ABIN401383 : Longati, Comoglio, Bardelli: Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene. in Current drug targets 2001 (PubMed)
    Show all 3 references for ABIN401383

  7. Human Polyclonal MET Primary Antibody for IHC (p), WB - ABIN401652 : Weidner, Sachs, Birchmeier: The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. in The Journal of cell biology 1993 (PubMed)
    Show all 2 references for ABIN401652

  8. Human Polyclonal MET Primary Antibody for IF, ELISA - ABIN1533596 : Hillier, Fulton, Fulton, Graves, Pepin, Wagner-McPherson, Layman, Maas, Jaeger, Walker, Wylie, Sekhon, Becker, OLaughlin, Schaller, Fewell, Delehaunty, Miner, Nash, Cordes, Du, Sun, Edwards et al.: The DNA sequence of human chromosome 7. ... in Nature 2003 (PubMed)
    Show all 2 references for ABIN1533596

  9. Human Polyclonal MET Primary Antibody for IHC (p), WB - ABIN389595 : Guo, Prins, Dang, Kuga, Iwanami, Soto, Lin, Huang, Akhavan, Hock, Zhu, Kofman, Bensinger, Yong, Vinters, Horvath, Watson, Kuhn, Robins, Mehta, Wen, DeAngelis, Prados, Mellinghoff, Cloughesy, Mischel: EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. in Science signaling 2009 (PubMed)
    Show all 2 references for ABIN389595

  10. Human Polyclonal MET Primary Antibody for DB - ABIN389596 : Xu, Xia, Baker, Zhou, Cha, Voorhees, Fisher: Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function. in The Journal of biological chemistry 2011 (PubMed)

More Antibodies against MET Interaction Partners

Human Met Proto-Oncogene (MET) interaction partners

  1. Therefore, our findings suggested miR (show MLXIP Antibodies)-34a could modulate human gastric cancer(GC) cell Cisplatin sensitivity by regulation of cell proliferation and apoptosis via targeting MET, potentially benefiting human GC treatment in the future.

  2. miR1 (show FSD1 Antibodies) expression inversely correlated with MET, cyclin D1 (show CCND1 Antibodies) and CDK4 (show CDK4 Antibodies) expression in esophageal squamous cell carcinoma cells.

  3. c-Met is expressed in malignant pleural mesothelioma, with significant differences in expression among histologic subtypes

  4. High c-MET expression is associated with esophageal squamous cell carcinoma.

  5. PIK3CA (show PIK3CA Antibodies) and MET may play an important role in oncogenesis of certain specific subtypes of head and neck cancer

  6. The expression of c-Met and ERbeta were significantly related to the basal-like phenotype in triple-negative breast cancer, however, high c-Met expression and basal-like phenotypes did not show a direct correlation with poor prognosis

  7. HGF (show HGF Antibodies)-induced FRA1 (show FOSL1 Antibodies) activation is associated with the fibrosis-dependent development of Hepatocellular Carcinoma.

  8. NEAT1 functions a molecular sponge for miR-449b-5p and leads to the upregulation of c-Met. This regulation menchaism promotes glioma pathogenesis and may provide a potential target for the prognosis and treatment of glioma.

  9. activation of HGF/c-MET signaling in an autocrine fashion leads to an aggressive phenotype in SS and targeting of this signaling exerts superior antitumor effects on c-MET-activated SS. HGF/c-MET expression status is a potential biomarker for identification of SS patients with a worse prognosis who can benefit from c-MET inhibitors.

  10. both EGCG and miR-1 mimic inhibited c-MET expression, and combination treatment with EGCG and c-MET inhibitor (crizotinib) had enhanced inhibitory effects on the growth of MG-63 and U-2OS cells. Taken together, these results suggest that EGCG has an anticancer effect on OS cells, at least partially, through regulating miR-1/c-MET interaction.

Mouse (Murine) Met Proto-Oncogene (MET) interaction partners

  1. study demonstrates that co-activation of AKT (show AKT1 Antibodies) and c-Met induces hepatocellular carcinoma development that depends on the mTORC1/FASN (show FASN Antibodies) pathway.

  2. Molecular and functional studies revealed that ectopic Met expression in limb mesenchyme does not alter HGF (show HGF Antibodies) expression patterns and levels, but impairs HGF (show HGF Antibodies) bioavailability

  3. miR-206 suppressed c-Met expression in gastric cancer and could function as a potent tumor suppressor in c-Met overexpressing tumors.

  4. Meg3 overexpression in insulinoma cells down-regulated the expression of the protooncogene c-met.

  5. our results support the concept of the acrosome as a lysosome-related organelle and provide evidence for the identification of MET as a tyrosine kinase receptor (show KDR Antibodies) that may play a role in fertilization.

  6. We show that a subset of adult calcitonin gene-related peptide (CGRP (show CALCA Antibodies))-expressing myenteric neurons produce MET, the receptor for hepatocyte growth factor (show HGF Antibodies).

  7. HGF and c-met inhibition by means of a novel monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and in mouse xenografts.

  8. facilitates T cell recruitment to the heart via CCR5 (show CCR5 Antibodies) receptor by inducing autocrine CCR5 (show CCR5 Antibodies) ligand release

  9. C-Met pathway is suggested to contribute to the lymphomagenesis in the MALT lymphoma after H. heilmannii infection.

  10. c-Met targeting enhances the effect of irradiation and chemical agents against malignant colon cells harboring a KRAS mutation.

Cow (Bovine) Met Proto-Oncogene (MET) interaction partners

  1. possible cooperative role of the EGF (show EGF Antibodies) and HGF (show HGF Antibodies) pathways and indicate that cross-talk between their respective receptors may modulate mammary gland development in the cow

MET Antigen Profile

Antigen Summary

The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with MET

  • met proto-oncogene (MET) antibody
  • met proto-oncogene (Met) antibody
  • met proto-oncogene (hepatocyte growth factor receptor) (MET) antibody
  • AI838057 antibody
  • AUTS9 antibody
  • c-met antibody
  • HGF antibody
  • Hgfr antibody
  • Par4 antibody
  • RCCP2 antibody

Protein level used designations for MET

HGF receptor , HGF/SF receptor , SF receptor , hepatocyte growth factor receptor , met proto-oncogene tyrosine kinase , proto-oncogene c-Met , scatter factor receptor , tyrosine-protein kinase Met , c-Met , HGF receptor c-Met

GENE ID SPECIES
4233 Homo sapiens
17295 Mus musculus
24553 Rattus norvegicus
403438 Canis lupus familiaris
280855 Bos taurus
654328 Sus scrofa
100126565 Oryctolagus cuniculus
Selected quality suppliers for anti-MET (MET) Antibodies
Did you look for something else?